Former President, International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine.
President, Brazilian Association of Pharmaceutical Medicine
Dr. Kesselring received his medical degree from University of São Paulo, Brazil and pursued further postgraduate training in Gynecology , Obstetrics and Mastology. He also received postgraduate qualifications in Clinical Pharmacology, Drug Development and Regulation at the Tufts Institute for Professional Development, USA.
For the past three decades Gustavo has been intimately involved in clinical research for both the public and private sector in Brazil as well as internationally . He was Director of Clinical Research for several multinational pharmaceutical companies in his country. He was appointed Director of the National Clinical Research Training Program for the Ministry of Health in Brazil while serving at the same time as Director of Clinical Research at the Science Institute, German Hospital Oswaldo Cruz, São Paulo.
From 2010 until 2015 he was Executive Director Latin America of the ViS Research Institute, which optimizes drug development by enabling access to a complete map of global clinical research infrastructure. ViS is current part of IMS Health.
Gustavo served as advisor for the World Medical Association for the revision of the Declaration of Helsinki (versions 2008 & 2013). He received awards by the American Academy of Clinical Research Professionals in 2011 and by the Drug Information Association in 2013 in recognition for his contributions to global clinical research and pharmaceutical medicine.
Dr. Kesselring is also the current President of the Brazilian Society of Pharmaceutical Medicine and serves in the board of other nonprofit organizations. He has published several articles on clinical research and medicines development and has been speaker and chairperson at international conferences in USA, Europe, Latin America and Asia.
IFAPP Academy provides an online, continuing professional development course, Medical Affairs in Medicines Development, resulting in the Professional Certification, Certified Medicines Development (CMD).